FDA Section 5 \u2022 cited verbatim

Pyrazinamide - Warnings and Precautions

The following warnings and precautions are taken directly from the US FDA-approved drug label for Pyrazinamide. This is the same information dispensing pharmacists read.

WARNINGS Patients started on pyrazinamide should have baseline serum uric acid and liver function determinations.

Those patients with preexisting liver disease or those at increased risk for drug related hepatitis (e.g., alcohol abusers) should be followed closely.

Pyrazinamide should be discontinued and not be resumed if signs of hepatocellular damage or hyperuricemia accompanied by an acute gouty arthritis appear.

Applies to YOU?

Some warnings apply only to specific age groups, health conditions, or other medicines. Ask GoDavaii AI to filter which of these 3+ warnings apply to your profile.

Ask Health AI \u2192